ETF Managers Group’s Enanta Pharmaceuticals ENTA Stock Holding History

ETF Managers Group’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$286K	Buy	7,080 +1,895	+37%	+$90.5K	0.01%	548
2022 Q4	$241K	Sell	5,185 -931	-15%	-$42.4K	0.01%	461
2022 Q3	$317K	Sell	6,116 -428	-7%	-$25K	0.01%	546
2022 Q2	$307K	Buy	6,544 +317	+5%	+$17.2K	0.01%	598
2022 Q1	$431K	Buy	6,227 +84	+1%	+$5.47K	0.01%	494
2021 Q4	$458K	Sell	6,143 -1,238	-17%	-$97.2K	0.01%	529
2021 Q3	$414K	Buy	7,381 +1,424	+24%	+$70.4K	0.01%	566
2021 Q2	$261K	Sell	5,957 -222	-4%	-$10.9K	﹤0.01%	595
2021 Q1	$297K	Sell	6,179 -3,587	-37%	-$179K	0.01%	589
2020 Q4	$406K	Sell	9,766 -1,478	-13%	-$65K	0.01%	439
2020 Q3	$504K	Buy	11,244 +5,424	+93%	+$263K	0.02%	305
2020 Q2	$285K	Buy	+5,820	New	+$301K	0.01%	440

Other funds holding ENTA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

KAM

Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ETF Managers Group's ENTA Position: Q1 2023 in Review

ETF Managers Group increased its Enanta Pharmaceuticals (ENTA) stake by 37% in Q1 2023, buying an estimated $90.5K and bringing the position to 7,080 shares worth $286K. The position accounts for 0.01% of the portfolio, ranked #548.

ETF Managers Group first reported a position in ENTA in Q2 2020 and has held it in 12 quarters since. The position peaked at $504K in Q3 2020. 145 funds tracked by Wall St. Rank hold ENTA as of Q1 2023.

ETF Managers Group held 7,080 shares of Enanta Pharmaceuticals worth $286K as of Q1 2023.
ETF Managers Group bought 1,895 Enanta Pharmaceuticals shares in Q1 2023, an estimated $90.5K.
Enanta Pharmaceuticals made up 0.01% of ETF Managers Group's portfolio in Q1 2023, its #548 holding.
ETF Managers Group first reported a position in Enanta Pharmaceuticals in Q2 2020 and has held it in 12 quarters since.
ETF Managers Group's Enanta Pharmaceuticals position peaked at $504K in Q3 2020.
145 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.